Catch up on the essentials
  • Zacks Research downgraded Texas Instruments (NASDAQ:TXN) from a "strong-buy" rating to a "hold" rating in a research note issued on Monday, according to the report carried by multiple outlets.
  • Coverage tied the rating change to the company's latest financial print and forward guidance.
  • Coverage catalogued a range of competing broker views alongside the Zacks action.

Selected from this article · 2026-09-23

Read on for the full picture

Zacks Research cuts its Texas Instruments rating from Strong Buy to Hold

Magnifying glass highlighting the word 'WIN' over financial charts. Enhance your business analysis vision.

Zacks Research downgraded Texas Instruments (NASDAQ:TXN) from a "strong-buy" rating to a "hold" rating in a research note issued on Monday, according to the report carried by multiple outlets. The shift leaves MarketBeat's consensus rating for the chipmaker at "Hold," with an average price target of $312.12 drawn from one Strong Buy, fifteen Buys, nine Holds and four Sells. Coverage of the action also noted that recent earnings-estimate revisions do not clearly indicate continued strength, leaving TXN sensitive to any slowdown in semiconductor demand or AI-infrastructure spending.

Q2 results and the Q3 2026 outlook under Zacks' lens

Coverage tied the rating change to the company's latest financial print and forward guidance. Texas Instruments reported second-quarter revenue of $5.46 billion, up 22.8% year-over-year, and earnings per share of $2.14, beating the $1.91 consensus by $0.23. Management has guided third-quarter EPS to a range of $2.23 to $2.57, and analysts on average expect full-year EPS of $8.45. Zacks' caution on estimate momentum stands against that backdrop, even as other commentators highlighted a 28% trailing operating cash flow less capital expenditures margin, a stronger, more delevered balance sheet and the company's role supplying analog and mixed-signal chips for data centers, robotics, automotive electrification and factory automation.

Street pricing and the $271 trading reference

Coverage catalogued a range of competing broker views alongside the Zacks action. Benchmark lifted its target from $315 to $360 with a "buy" on Thursday, July 23, while Wells Fargo raised its target from $300 to $310 with an "equal weight" call on the same date and Morgan Stanley moved its target from $230 to $255 with an "underweight" rating. Stifel Nicolaus lifted its target from $340 to $360 on Wednesday, June 24, Susquehanna raised its target from $300 to $340 with a "positive" rating on Tuesday, July 21, Robert W. Baird lifted its target from $300 to $385 with an "outperform" rating on Thursday, July 23, and Arete Research set a $405 target with a "buy" rating on Wednesday, July 29. Evercore reissued an "outperform" rating with a $330 target on Thursday, July 23, while Citigroup restated a "buy" rating on Tuesday, July 14. One analytical framework cited in coverage rates the stock Accumulate below $271, Hold between $271 and $345, and Distribute above $345, with TXN opening at $271.41 in the coverage, a 50-day moving average of $271.60 and a 200-day moving average of $265.61.

Capital return and shareholder communications

Separate coverage highlighted shareholder-return actions outside the rating change. Texas Instruments raised its quarterly dividend 7% to $1.52 per share, extending a record of 23 consecutive annual increases. A Form 4-style disclosure cited in coverage shows Vice President Tsedeniya Abraham selling 7,000 shares on Thursday, August 27 at an average price of $264.63, a transaction valued at about $1,852,410 that reduced her position by 23.19% to 23,181 shares.

Share this article

FacebookX

3 sources

Sources